Penserra Capital Management LLC Oric Pharmaceuticals, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$12.01 - $20.3 $10,809 - $18,270	-900 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$15.9 - $25.22 $1,033 - $1,639	65 Added 7.78%	900 $18,000
Q2 2021 Aug 12, 2021	BUY	$17.37 - $25.34 $173 - $253	10 Added 1.21%	835 $14,000
Q1 2021 May 13, 2021	SELL	$23.67 - $36.85 $355 - $552	-15 Reduced 1.79%	825 $20,000
Q4 2020 Feb 12, 2021	BUY	$20.32 - $39.8 $17,068 - $33,432	840 New	840 $28,000

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.